长江生命科技(00775)宣布成立顺谱医药科技有限公司专注推动旗下治疗性癌症疫苗组合的发展

智通财经03-10

智通财经APP讯，长江生命科技(00775)发布公告，宣布成立公司全资附属公司顺谱医药科技有限公司(Sequencio Therapeutics Company Limited，“Sequencio”)，专注推动旗下治疗性癌症疫苗组合的发展。公司成立 Sequencio，将旗下治疗性癌症疫苗研发项目整合至一个专注平台，充分体现公司锐意拓展此新兴癌症免疫疗法领域的策略方针。Sequencio 专注...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2618474938?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-10 16:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618474938","market":"fut","top_or_hot":-1,"title":"长江生命科技(00775)宣布成立顺谱医药科技有限公司 专注推动旗下治疗性癌症疫苗组合的发展","media":"智通财经","content":"<div>\n<p>智通财经APP讯，长江生命科技(00775)发布公告，宣布成立公司全资附属公司顺谱医药科技有限公司(Sequencio Therapeutics Company Limited，“Sequencio”)，专注推动旗下治疗性癌症疫苗组合的发展。公司成立 Sequencio，将旗下治疗性癌症疫苗研发项目整合至一个专注平台，充分体现公司锐意拓展此新兴癌症免疫疗法领域的策略方针。Sequencio 专注...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1412149.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>长江生命科技(00775)宣布成立顺谱医药科技有限公司 专注推动旗下治疗性癌症疫苗组合的发展</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n长江生命科技(00775)宣布成立顺谱医药科技有限公司 专注推动旗下治疗性癌症疫苗组合的发展\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-10 16:57 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1412149.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，长江生命科技(00775)发布公告，宣布成立公司全资附属公司顺谱医药科技有限公司(Sequencio Therapeutics Company Limited，“Sequencio”)，专注推动旗下治疗性癌症疫苗组合的发展。公司成立 Sequencio，将旗下治疗性癌症疫苗研发项目整合至一个专注平台，充分体现公司锐意拓展此新兴癌症免疫疗法领域的策略方针。Sequencio 专注...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1412149.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159938","symbol_name":"医药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1412149.html","article_id":"2618474938","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618474938","pubTimestamp":1773133025,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，长江生命科技 发布公告，宣布成立公司全资附属公司顺谱医药科技有限公司，专注推动旗下治疗性癌症疫苗组合的发展。公司成立 Sequencio，将旗下治疗性癌症疫苗研发项目整合至一个专注平台，充分体现公司锐意拓展此新兴癌症免疫疗法领域的策略方针。Sequencio 肩负长远愿景——重塑癌症治疗模式，从引导短暂性肿瘤缩小，迈向透过免疫系统达致长期可控的缓解。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159646":"疫苗","159938":"医药","00775":"长江生命科技","BK1515":"抗疫概念","BK1161":"生物科技","BK1569":"长和系","BK1574":"生物医药B类股","09939":"开拓药业-B"},"translate_title":"CK Life Sciences (00775) announced the establishment of Shunpu Pharmaceutical Technology Co., Ltd. to focus on promoting the development of its therapeutic cancer vaccine portfolio","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159646":1.5,"159938":1.5,"00775":1.5,"09939":1.5},"content_text":"智通财经APP讯，长江生命科技(00775)发布公告，宣布成立公司全资附属公司顺谱医药科技有限公司(Sequencio Therapeutics Company Limited，“Sequencio”)，专注推动旗下治疗性癌症疫苗组合的发展。公司成立 Sequencio，将旗下治疗性癌症疫苗研发项目整合至一个专注平台，充分体现公司锐意拓展此新兴癌症免疫疗法领域的策略方针。Sequencio 专注研发能激活患者自身免疫系统对抗癌细胞的治疗性疫苗，旨在维持良好安全性的前提下，实现持久而稳定的病情缓解，从而应对现有标准疗法的关键局限。Sequencio 肩负长远愿景——重塑癌症治疗模式，从引导短暂性肿瘤缩小，迈向透过免疫系统达致长期可控的缓解。疫苗的研发与设计将由内部团队进行，并结合内部科研实力与外部伙伴的合作，务求加快整体发展步伐。Sequencio的临床前组合，涵盖公司针对滋养层细胞表面抗原  2(TROP2)的试验性癌症疫苗。于临床前乳腺癌及结直肠癌小鼠研究中，该候选疫苗成功诱发强大T细胞免疫反应，并能完全(100%)有效抑制肿瘤生长。此外，该组合亦包括分别针对黑色素瘤优先表现抗 原 ( Preferentially Expressed Antigen in Melanoma “ PRAME ” ) 、 细胞程式性死亡 — 配体 1(programmed cell death ligand 1“PD-L1”)、B7-H3免疫检查点(B7 homolog 3 “B7-H3”)，以及 Claudin 6 蛋白质等候选疫苗。随着公司持有 Sequencio 、 TransCode及 Dogwood ， 公司已建立研发平台，其多元化研发组合涵盖早期及后期项目，聚焦于当前医疗需求尚未得到充分满足的领域。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2618474938","isCrawlerRequest":true}

长江生命科技(00775)宣布成立顺谱医药科技有限公司 专注推动旗下治疗性癌症疫苗组合的发展

精彩评论

长江生命科技(00775)宣布成立顺谱医药科技有限公司专注推动旗下治疗性癌症疫苗组合的发展